Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marko Repic"'
Autor:
Rebecca Senter, Rogely Boyce, Marko Repic, Emily Walsh Martin, Monika Chabicovsky, Geneviève Langevin-Carpentier, Agathe Bédard, Neil Bodick
Publikováno v:
Human gene therapy. 33(9-10)
Osteoarthritis (OA) is a disabling, degenerative disease characterized by progressive cartilage and bone damage. There remains a need for local therapies that, following a single injection, can provide long-term pain relief and functional improvement
Autor:
Andreia C. Gomes, Eva Steinhuber, Mario Kuttke, Vanessa Mühlgrabner, Eugénia Nogueira, Alexander Zwirzitz, Gordana Wozniak-Knopp, Marko Repic, Anna Ohradanova-Repic, Ana Preto, Gernot Schabbauer, Hannes Stockinger, Ingrid Hartl, Miloslav Suchánek, Marek Prouza, Vaclav Horejsi, Artur Cavaco-Paulo
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Liposomes functionalized with monoclonal antibodies or their antigen-binding fragments have attracted much attention as specific drug delivery devices for treatment of various diseases including cancer. The conjugation of antibodies to liposomes is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab3c4eb67bd9545322f7a88338381870
https://hdl.handle.net/1822/51164
https://hdl.handle.net/1822/51164
Publikováno v:
Nature Reviews Neuroscience. 16:647-659
Neural circuit function can be drastically affected by variations in the number of cells that are produced during development or by a reduction in adult cell number due to disease. Unlike many other organs, the brain is unable to compensate for such
Autor:
Thomas R Burkard, Jürgen A. Knoblich, Anoop Kavirayani, Marko Repic, Joshua A. Bagley, Christian Krauditsch, Shan Bian, Zhenming Guo
Publikováno v:
Nature Methods. 15:748-748
In the originally published paper, the "before" image for the afatinib condition in Fig. 6c was incorrect. Instead of an image displaying a GBM-3 neoplastic organoid before afatinib treatment, this panel showed an image from the GBM-2 control (DMSO)
Autor:
Martina Takacova, Peter Radvak, Hynek Strnad, Marko Repic, Silvia Pastorekova, Jaromir Pastorek, Eliska Svastova, Juraj Kopacek, Lucia Csaderova
Publikováno v:
Oncology Reports; Vol
Oncology Reports
Oncology Reports
Carbonic anhydrase IX (CA IX) is a well-recognized hypoxia marker with promising diagnostic and therapeutic value. CA IX regulates the pH in hypoxic tumor cells and, thereby, contributes to microenvironmental acidosis and cell migration. To gain a be
Autor:
Marko Repic, Zhenming Guo, Anoop Kavirayani, Christian Krauditsch, Joshua A. Bagley, Thomas R Burkard, Jürgen A. Knoblich, Shan Bian
Publikováno v:
Nature methods
Nature Methods
Nature Methods
Brain tumors are among the most lethal and devastating cancers. Their study is limited by genetic heterogeneity and the incompleteness of available laboratory models. Three-dimensional organoid culture models offer innovative possibilities for the mo
Autor:
Senter, Rebecca, Boyce, Rogely, Repic, Marko, Martin, Emily Walsh, Chabicovsky, Monika, Langevin-Carpentier, Geneviève, Bédard, Agathe, Bodick, Neil
Publikováno v:
Human Gene Therapy; May2022, Vol. 33 Issue 9/10, p541-549, 9p
Autor:
Fededa, Juan Pablo, Esk, Christopher, Mierzwa, Beata, Stanyte, Rugile, Yuan, Shuiqiao, Zheng, Huili, Ebnet, Klaus, Yan, Wei, Knoblich, Juergen A, Gerlich, Daniel W
Publikováno v:
EMBO Journal; 11/15/2016, Vol. 35 Issue 22, p2386-2398, 13p
Autor:
Hyun Jung Kim
This book will examine the relevant biological subjects involved in biomimetic microengineering as well as the design and implementation methods of such engineered microdevices. Physiological topics covered include regeneration of complex responses o
Comparing business regulation in 181 economies. Doing Business 2009 is the sixth in a series of annual reports comparing business regulations in 181 economies. Doing Business 2009 measures regulations affecting 10 areas of everyday business: Starting